Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

PHASE4TerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

May 31, 2006

Study Completion Date

July 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Trelstar

As labeled

DRUG

Lupron

As labeled

DRUG

Zoladex

As labeled

Trial Locations (11)

11201

Brooklyn Heights Urology Associates, Brooklyn

Jazrawi-Atallah, P.C., Brooklyn

17815

Raj P. Chopra MD, PC, Bloomsburg

28001

Albemarle Urology Clinic, PA, Albemarle

34470

UroSearch, Ocala

71913

Heritage Physician Group - Urology Department, Hot Springs

89109

Scott A Slavis, MD, PC, Las Vegas

92404

San Bernardino Urological Associates Medical Group, San Bernardino

93710

California Oncology of the Central Valley, Fresno

85712-5803

Arizona Urologic Specialists, Tucson

08070

Shaukat M Qureshi, MD, Pennsville

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Manyak, Michael, M.D.

INDIV

collaborator

Watson Pharmaceuticals

INDUSTRY

lead

Pharmatech

INDUSTRY